Enhancing Pharmacovigilance from the US Experience: Current Practices and Future Opportunities.

Veronique F KugenerEric S FreedlandKenneth I MaynardOmar AimerPeggy S WebsterMaribel Salas Maxine Gossell-Williams

Published in: Drug safety (2021)

This review is intended to present perspectives from the US experience in enhancing pharmacovigilance on current practices and future opportunities. Best practices concepts could be applied worldwide through the presentation of how three pillars of pharmacovigilance: (1) medical and scientific excellence, (2) operational and compliance excellence, and (3) knowledge sharing and experts development in the field could serve as a framework for the establishment of an efficient and successful global pharmacovigilance system.

Keyphrases

healthcare
adverse drug
primary care
drug induced
current status
electronic health record
social media